TY - JOUR
T1 - Eating, sleeping and sexual function disorders in women with polycystic ovary syndrome (PCOS)
T2 - A systematic review and meta-analysis
AU - Thannickal, Aneesa
AU - Brutocao, Claire
AU - Alsawas, Mouaz
AU - Morrow, Allison
AU - Zaiem, Feras
AU - Murad, Mohammad Hassan
AU - Javed Chattha, Asma
N1 - Funding Information:
We would like to acknowledge the contributions of the varying department of the Mayo Clinic, Rochester MN which include but are not limited to the division of preventive medicine, paediatric adolescent gynaecology and obstetrics and gynaecology. We would also like to acknowledge the contributions of the health analytic department.
Publisher Copyright:
© 2020 John Wiley & Sons Ltd
PY - 2020/4/1
Y1 - 2020/4/1
N2 - Purpose: We aim to evaluate the association of PCOS with eating, sleeping and sexual function disorders. Methods: A comprehensive search including MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus through 01 August 2018 was conducted for studies reporting the prevalence of any eating, sleep or sexual function disorders in patients with PCOS. Independent reviewers selected studies and extracted data. A random-effects model was utilized to generate pooled odds ratio (OR) and 95% confidence intervals (CI) for binary outcomes, and mean difference (MD) and 95% CI for continuous outcomes. Results: We included 36 studies reporting on 349,529 patients. Compared to women without PCOS, women with PCOS were more likely to have bulimia nervosa (OR 1.37; %CI, 1.17 to 1.60), binge eating (OR 2.95; 95%CI, 1.61 to 5.42), or any eating disorder (OR 1.96; 95% CI 1.18 to 3.24); but not anorexia nervosa (OR 0.92; 95%CI, 0.78 to 1.10). Women with PCOS were more likely to have sleep disorders like hypersomnia (OR 4.39; %CI, 1.07 to 18.07) and obstructive sleep apnoea (OR 10.81; %CI, 2.39 to 48.83). Women with PCOS had lower sexual satisfaction as measured on a visual analogue scale (MD −29.67; 95% CI, −36.97 to −22.37), but no difference in Total Female Sexual Function Index (MD −0.06; 95% CI, −0.51 to 0.38). Conclusion: PCOS can be associated with an increased risk of eating and sleeping disorders as well as decreased sexual satisfaction. Screening for these disorders in women with PCOS may allow early intervention and improve quality of life.
AB - Purpose: We aim to evaluate the association of PCOS with eating, sleeping and sexual function disorders. Methods: A comprehensive search including MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus through 01 August 2018 was conducted for studies reporting the prevalence of any eating, sleep or sexual function disorders in patients with PCOS. Independent reviewers selected studies and extracted data. A random-effects model was utilized to generate pooled odds ratio (OR) and 95% confidence intervals (CI) for binary outcomes, and mean difference (MD) and 95% CI for continuous outcomes. Results: We included 36 studies reporting on 349,529 patients. Compared to women without PCOS, women with PCOS were more likely to have bulimia nervosa (OR 1.37; %CI, 1.17 to 1.60), binge eating (OR 2.95; 95%CI, 1.61 to 5.42), or any eating disorder (OR 1.96; 95% CI 1.18 to 3.24); but not anorexia nervosa (OR 0.92; 95%CI, 0.78 to 1.10). Women with PCOS were more likely to have sleep disorders like hypersomnia (OR 4.39; %CI, 1.07 to 18.07) and obstructive sleep apnoea (OR 10.81; %CI, 2.39 to 48.83). Women with PCOS had lower sexual satisfaction as measured on a visual analogue scale (MD −29.67; 95% CI, −36.97 to −22.37), but no difference in Total Female Sexual Function Index (MD −0.06; 95% CI, −0.51 to 0.38). Conclusion: PCOS can be associated with an increased risk of eating and sleeping disorders as well as decreased sexual satisfaction. Screening for these disorders in women with PCOS may allow early intervention and improve quality of life.
KW - eating disorders
KW - polycystic ovary syndrome
KW - sexual dysfunction
KW - sleeping disorders
UR - http://www.scopus.com/inward/record.url?scp=85078823503&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85078823503&partnerID=8YFLogxK
U2 - 10.1111/cen.14153
DO - 10.1111/cen.14153
M3 - Article
C2 - 31917860
AN - SCOPUS:85078823503
SN - 0300-0664
VL - 92
SP - 338
EP - 349
JO - Clinical Endocrinology
JF - Clinical Endocrinology
IS - 4
ER -